MAP2K7 and central nervous system cancer: Inhibition of HDAC6 reduces glioma cell proliferation and invasion by destabilizing MAP2K7 protein, decreasing JNK and c-Jun activation, and subsequently downregulating cyclin D1 and matrix metalloproteinases (35).